Browse > Article

Cytologic Features of Cancers Metastatic to the Lung and Diagnostic Usefulness of Immunohistochemistry : Distinction Between Primary and Secondary Lung Tumors  

Oh, Young-Lyun (Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Publication Information
The Korean Journal of Cytopathology / v.19, no.1, 2008 , pp. 16-26 More about this Journal
Abstract
The lungs are one of the most common visceral sites for metastatic disease. The identification of a metastasis from a second primary lung tumor is clinically important for patients with pulmonary metastases of an extrathoracic origin. Although the cytologic features of metastatic tumors involving the lung have been extensively described, making the cytologic diagnosis is usually not easy in the absence of clinical information. However, the immunohistochemical staining for many tumor markers and the different expressions of cytokeratin 7 and 20 are very useful in the diagnosis. This review presents the cytomorphological spectrum of metastatic tumors along with the immunohistochemical findings.
Keywords
Lung; Metastasis; Cytology; Immunohistochemistry;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Tan D, Zander DS. Immunohistochemistry for assessment of pulmonary and pleural neoplasms: a review and update. Int J Clin Exp Pathol 2008:1:19-31
2 McCormack PM, Attiyeh FF. Resected pulmonary metastases from colorectal cancer. Dis Colon Rectum 1979;22:553- 6   DOI
3 Chhieng DC, Cangiarella JF, Zakowski MF, Goswami S, Cohen JM, Yee HT. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Cancer 2001;93:330-6   DOI
4 Brown RW, Campagna LB, Dunn JK, Cagle PT. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site. Am J Clin Pathol 1997;107:12- 9   DOI
5 Ordonez NG. The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma. Am J Surg Pathol 2003;27:1031-51   DOI   ScienceOn
6 Simsir A, Chhieng D, Wei XJ, Yee H, Waisman J, Cangiarella J. Utility of CD10 and RCCma in the diagnosis of metastatic conventional renal-cell adenocarcinoma by fine-needle aspiration biopsy. Diagn Cytopathol 2005;33:3-7   DOI   ScienceOn
7 Onofre AS, Pomjanski N, Buckstegge B, Bocking A. Immunocytochemical diagnosis of hepatocellular carcinoma and identification of carcinomas of unknown primary metastatic to the liver on fine-needle aspiration cytologies. Cancer 2007;111:259-68   DOI   ScienceOn
8 Sugitani I, Fujimoto Y, Yamamoto N. Papillary thyroid car- cinoma with distant metastases: survival predictors and the importance of local control. Surgery 2008;143:35-42   DOI   ScienceOn
9 Kim K, Naylor B, Han IH. Fine needle aspiration cytology of sarcomas metastatic to the lung. Acta Cytol 1986;30:688- 94
10 Renshaw AA, Nappi D, Cibas ES. Cytology of metastatic adenocarcinoma of the prostate in pleural effusions. Diagn Cytopathol 1996;15:103-7   DOI   ScienceOn
11 Chen C, Hoda RS, Hoda SA. Intranuclear cytoplasmic inclusions in the differential diagnosis of papillary thyroid carcinoma and bronchioloalveolar carcinoma. Diagn Cytopathol 1998;18:384-6   DOI   ScienceOn
12 Kaufmann O, Volmerig J, Dietel M. Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas. Am J Clin Pathol 2000;113:683-7   DOI   ScienceOn
13 Bassily NH, Vallorosi CJ, Akdas G, Montie JE, Rubin MA. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma. Am J Clin Pathol 2000;113:383-8   DOI   ScienceOn
14 Renshaw AA, Madge R, Granter SR. Intracytoplasmic eosinophilic inclusions (Melamed-Wolinska bodies). Association with metastatic transitional cell carcinoma in pleural fluid. Acta Cytol 1997;41:995-8   DOI   ScienceOn
15 Moll R, Laufer J, Wu XR, Sun TT. Uroplakin III, a specific membrane protein of urothelial umbrella cells, as a histological markers for metastatic transitional cell carcinomas. Verh Dtsch Ges Pathol 1993;77:260-5
16 Memeo L, Jhang J, Assaad AM, et al. Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma. Am J Clin Pathol 2007;127:225-9   DOI   ScienceOn
17 Siddiqui MT, Saboorian MH, Gokaslan ST, Ashfaq R. Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration samples. Cancer 2002;96:49-52   DOI
18 Layfield LJ, Jones C, Hirschowitz S. Statistical analysis of cytologic features useful in separation of metastatic urothelial carcinoma from other metastatic epithelial malignancies. Diagn Cytopathol 2003;29:334-8   DOI   ScienceOn
19 McGregor DK, Khurana KK, Cao C, et al. Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody 'Renal Cell Carcinoma Marker'. Am J Surg Pathol 2001;25:1485-92   DOI   ScienceOn
20 Gokden N, Mukunyadzi P, James JD, Gokden M. Diagnostic utility of renal cell carcinoma marker in cytopathology. Appl Immunohistochem Mol Morphol 2003;11:116-9   DOI   ScienceOn
21 Geurts TW, Nederlof PM, van den Brekel MW, et al. Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary? Clin Cancer Res 2005;11:6608-14   DOI   ScienceOn
22 Johnson TL, Kini SR. Cytologic features of metastatic transitional cell carcinoma. Diagn Cytopathol 1993;9:270-8   DOI   ScienceOn
23 Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 2000;13:962-72   DOI   ScienceOn
24 Sack MJ, Roberts SA. Cytokeratins 20 and 7 in the differential diagnosis of metastatic carcinoma in cytologic specimens. Diagn Cytopathol 1997;16:132-6   DOI   ScienceOn
25 Koss LG, Melamed MR, Goodner JT. Pulmonary Cytology-a brief survey of diagnostic results from July 1st 1952 until December 31st, 1960. Acta Cytol 1964;8:104-13
26 Flint A, Lloyd RV. Colon carcinoma metastatic to the lung. Cytologic manifestations and distinction from primary pulmonary adenocarcinoma. Acta Cytol 1992;36:230-5
27 David D. Diagnostic Immunohistochemistry: Immunohistology of lung and pleural neoplasms. Second edition. Churchill Livingstone, 2006
28 Renshaw AA, Haja J, Wilbur DC, Miller TR. Fine-needle aspirates of hepatocellular carcinoma that are misclassified as adenocarcinoma: correlating cytologic features and performance in the College of American Pathologists Nongynecologic Cytology Program. Arch Pathol Lab Med 2006;130:19-22
29 Gaeta M, Volta S, Scribano E, Loria G, Vallone A, Pandolfo I. Air-space pattern in lung metastasis from adenocarcinoma of the GI tract. J Comput Assist Tomogr 1996;20:300-4   DOI   ScienceOn
30 Koss LG. Melamed MR. Koss' Diagnostic Cytology And Its Histopathologic Bases: Tumors of the lung. 5th edition. Lippincott Williams & Wilkins, 2005
31 Langner C, Ratschek M, Tsybrovskyy O, Schips L, Zigeuner R. P63 immunoreactivity distinguishes upper urinary tract transitional-cell carcinoma and renal-cell carcinoma even in poorly differentiated tumors. J Histochem Cytochem 2003; 51:1097-9   DOI   ScienceOn
32 Shin HJ, Caraway NP. Fine-needle aspiration biopsy of metastatic small cell carcinoma from extrapulmonary sites. Diagn Cytopathol 1998;19:177-81   DOI   ScienceOn
33 Liu J, Farhood A. Immunostaining for thyroid transcription factor-1 on fine-needle aspiration specimens of lung tumors: a comparison of direct smears and cell block preparations. Cancer 2004;102:109-14   DOI   ScienceOn
34 Yoneda KY, Louie S, Shelton DK. Approach to pulmonary metastases. Curr Opin Pulm Med 2000;6:356-63   DOI   ScienceOn
35 Loy TS, Chapman RK, Diaz-Arias AA, Bulatao IS, Bickel JT. Distribution of BCA-225 in adenocarcinomas. An immunohistochemical study of 446 cases. Am J Clin Pathol 1991;96: 326-9   DOI
36 Ciampa A, Fanger G, Khan A, Rock KL, Xu B. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas. Cancer 2004;102:368-72   DOI   ScienceOn
37 Kushitani K, Takeshima Y, Amatya VJ, Furonaka O, Sakatani A, Inai K. Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma. Pathol Int 2007;57:190-9   DOI   ScienceOn
38 Giardini R, Martelli G, Rilke F, Pilotta S. Diagnostic problems of second primary malignancies detected by fine-needle aspiration cytology. Cancer 1993;72:2716-22   DOI   ScienceOn
39 Di Nunno L, Larsson LG, Rinehart JJ, Beissner RS. Estrogen and progesterone receptors in non-small cell lung cancer in 248 consecutive patients who underwent surgical resection. Arch Pathol Lab Med 2000;124:1467-70
40 Schulten MF, Heiskell CA, Shields TW. The incidence of solitary pulmonary metastasis from carcinoma of the large intestine. Surg Gynecol Obstet 1976;143:727-9
41 Goldstein NS, Thomas M. Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies. Am J Clin Pathol 2001;116:319-25   DOI   ScienceOn
42 Copeland JN, Amin MB, Humphrey PA, Tamboli P, Ro JY, Gal AA. The morphologic spectrum of metastatic prostatic adenocarcinoma to the lung: special emphasis on histologic features overlapping with other pulmonary neoplasms. Am J Clin Pathol 2002;117:552-7   DOI   ScienceOn
43 Renshaw AA, Madge R. Cercariform cells for helping distinguish transitional cell carcinoma from non-small cell lung carcinoma in fine needle aspirates. Acta Cytol 1997;41:999-1007   DOI   ScienceOn
44 Koizumi JH, Schron DS. Cytologic features of colonic adenocarcinoma. Differences between primary and metastatic neoplasms. Acta Cytol 1997;41:419-26   DOI   ScienceOn
45 Parwani AV, Ali SZ. Prostatic adenocarcinoma metastases mimicking small cell carcinoma on fine-needle aspiration. Diagn Cytopathol 2002;27:75-9   DOI   ScienceOn